What is the main financial metric discussed for BioNexus Gene Lab Corp (NASDAQ: BGLC) in this article?

The main financial metric discussed is the Enterprise Value to EBITDA forward ratio for BioNexus Gene Lab Corp (NASDAQ: BGLC). The article states that it 'provides financial data for BioNexus Gene Lab Corp (NASDAQ: BGLC), specifically focusing on its Enterprise Value to EBITDA forward.' This ratio is presented within the context of a TradingView financial analysis page, which hosts market information for the company.

Where is the financial data for BioNexus Gene Lab Corp (NASDAQ: BGLC) sourced from, according to the article?

According to the article, the financial data — specifically the Enterprise Value to EBITDA forward — is sourced from a TradingView financial analysis page. The body explicitly states: 'The data is presented within the context of a TradingView financial analysis page, detailing market information for the company.' No other source or platform is mentioned.